Add like
Add dislike
Add to saved papers

Nanoparticles in detection and treatment of lymph node metastases: an update from the point of view of administration routes.

INTRODUCTION: Lymphatic vessels are the preferential route of most solid tumors to spread their metastases in the body. Therefore, the individuation and elimination of cancer cells within the lymphatic system (LS) is an important goal. Nanoparticles (NPs), thanks to their small size, represent suitable carriers for imaging and for chemotherapeutic transport to the LS. An update of different nanoparticle delivery systems developed for the detection and treatment of lymphatic metastases has been made, classified from the point of view of the administration routes used. Areas covered: The role of the LS in tumor progression and importance of treatment and imaging strategies of lymphatic metastases; classification, with regard the administration route, of nanoparticle delivery system used to target lymph node (LN) metastases. Expert opinion: The NPs are a promising approach for the treatment and detection of lymphatic metastases. However, further studies are necessary to evaluate their efficacy in human clinical application.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app